Back to results
US 2019/0350952 A1Published application
Cytotoxic agents for the treatment of cancer
AssigneeCytRx Corporation
InventorDaniel Levitt
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
Claims12
-18. (canceled)
A pharmaceutical composition for use in the treatment of brain cancer comprising a therapeutically effective substance, wherein the therapeutically effective substance comprises DOXO-EMCH
- or a pharmaceutically acceptable salt thereof and wherein the therapeutically effective substance binds to serum albumin.
-29. (canceled)
-72. (canceled)
Dependencies are inferred from the claim text.